≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Chromophobe cell carcinoma of kidney (controls excluding all cancers)

PheWeb

C3_KIDNEY_CHROMOPHOBE_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cancer registry: Topography ICD-O-3 C64
Cancer registry: Morphology ICD-O-3 8317
Cancer registry: Behaviour codes 3

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

96

diagram downward connector
C3_KIDNEY_CHROMOPHOBE_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF9
Name in latin Carcinoma in situ labii (oris)

Not enough data for upset plot.

Or the full data table

Similar endpoints

↥

List of similar endpoints to Chromophobe cell carcinoma of kidney (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 96 41 55
Unadjusted prevalence (%) 0.03 0.02 0.03
Mean age at first event (years) 64.46 61.77 66.47

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_KIDNEY_CHROMOPHOBE_EXALLC – Chromophobe cell carcinoma of kidney (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Chromophobe cell carcinoma of kidney (controls excluding all cancers)
after Chromophobe cell carcinoma of kidney (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Chromophobe cell carcinoma of kidney (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.